230
Participants
Start Date
May 31, 2006
Primary Completion Date
July 31, 2006
Study Completion Date
September 30, 2010
Haemophilus influenzae type b- and meningococcal (vaccine)
Intramuscular injection into the thigh as primary vaccination at 2, 4 and 6 months of age (group HibMenC) and as booster dose at 14 months of age (groups HibMenC and group NeisPoo).
Infanrix™ penta
Intramuscular injection into the thigh as primary vaccination at 2, 4 and 6 months of age
Infanrix™ hexa
Intramuscular injection into the thigh as primary vaccination at 2, 4 and/or 6 months of age (groups NeisPoo and MenCCRM) and/or as booster dose at 14 months of age (group MenCCRM).
Engerix-B
Intramuscular injection into the thigh as a birth dose
NeisVac-C™
Intramuscular injection into the thigh as primary vaccination at 2 and 4 months of age.
Infanrix™ IPV/HIB
Intramuscular injection into the thigh as primary vaccination at 4 months of age
Meningitec™
Intramuscular injection into the thigh as primary vaccination at 2, 4 and 6 months of age
GSK Investigational Site, Girona
GSK Investigational Site, Madrid
GSK Investigational Site, Marid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Getafe/Madrid
GSK Investigational Site, Móstoles/Madrid
GSK Investigational Site, Málaga
GSK Investigational Site, Vélez-Málaga / Málaga
GSK Investigational Site, Valladolid
GSK Investigational Site, Almería
GSK Investigational Site, Burgos
Lead Sponsor
GlaxoSmithKline
INDUSTRY